Saturday, September 28, 2013

Frequency of Bone Mineral Density Testing for Predicting Fracture Risk Questioned By Study

Medindia Health News
Medindia largest health website in india. // via fulltextrssfeed.com 
Refresh your vocabulary.

Learn a new word everyday by subscribing to Word of the Day. A great tool if you're studying for the GRE, GMAT or LSAT, or simply want to enhance your lexicon.
From our sponsors
Frequency of Bone Mineral Density Testing for Predicting Fracture Risk Questioned By Study
Sep 28th 2013, 19:33


Bone mineral density testing is important in the management of osteoporosis. Guidelines for initiating pharmacologic treatment for osteoporosis are based on BMD in conjunction with risk classification scores. "Despite the utility of BMD, the value of repeating a BMD screening test is unclear," according to background information in the article. Currently, Medicare reimburses for BMD screening every 2 years regardless of baseline BMD and without a restriction on the number of repeat tests. Twenty-two percent of screened Medicare beneficiaries receive a repeat BMD test within 3 years, on average 2.2 years apart. "Given the priority of reducing health care costs while improving quality of care, it is important to determine whether repeat BMD screening is useful."

Sarah D. Berry, M.D., M.P.H., of the Institute for Aging Research, Hebrew SeniorLife, Boston, and colleagues conducted a study to determine whether changes in BMD after 4 years provide additional information on fracture risk beyond baseline BMD. The population-based cohort study involved 310 men and 492 women from the Framingham Osteoporosis Study with 2 measures of femoral neck BMD taken four years apart between 1987-1999. The primary measured outcome was risk of hip or other major osteoporotic fracture through 2009 or 12 years following the second BMD measure. Average age was 75 years.

After a median (midpoint) follow-up of 9.6 years, the average BMD change was -0.6 percent per year. During follow-up, 113 participants (14.1 percent) experienced 1 or more major osteoporotic fractures (88 hip, 24 spine, 5 shoulder, and 33 forearm fractures). The net change in the percentage of participants with a hip fracture correctly reclassified with a second BMD measure was 3.9 percent; the net change in the percentage of participants without hip fracture correctly reclassified by a second BMD measure was -2.2 percent. The researchers found that the net change in the percentage of participants with a major osteoporotic fracture correctly reclassified with a second BMD measure was 9.7 percent; the net change in percentage of participants without major osteoporotic fracture correctly reclassified by a second BMD measure was -4.6 percent.

The authors conclude that for older patients not undergoing treatment for osteoporosis, "� BMD change provided little additional information beyond baseline BMD for the clinical management of osteoporosis." The second BMD measure reclassified a small proportion of individuals, and it is unclear whether this reclassification justifies the current U.S. practice of performing serial BMD tests at 2.2-year intervals. "Further study is needed to determine an appropriate rescreening interval and to identify individuals who might benefit from more frequent rescreening intervals."

Source-Eurekalert

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment